Tariffs & sustainability: Why Indian pharma can no longer treat them as separate conversations
For a long time, Indian pharmaceutical companies could treat trade policy as a background variable. The real focus in the last…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Saransh Chaudhary
Driving innovation in India’s pharma R&D through cell and gene therapy
Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre highlights how…
Venus Remedies secures WHO GDP endorsement for pharma logistics
Extending its reach directly to pharmacies and small retailers, Venus Remedies now operates a parallel online delivery system
Venus Remedies secures marketing authorisation for Enoxaparin in Indonesia
Approval expands company’s footprint in Southeast Asia’s growing anticoagulant market
Mixed reactions from pharma to Union Budget 2025
Appreciate extending full exemption and concessional tariffs to bulk drugs used for selected lifesaving drugs but hope for…
Strengthening drug security through a resilient and affordable pharmaceutical supply chain
Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre explains strategies to…
Expectations from Budget 2024: Govt must prioritise funds for digital integration in pharma supply…
Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre (VMRC) also states…
The power of AI is the future of pharma
As a part of Express Pharma’s January 2023 cover story, Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and…
Pressing need for new antibiotic research reimbursement models
Classifying novel antibiotics that target drug-resistant infections as ‘reserve’ drugs meant to be used sparingly when no other…